FIGURE 2.
Effects of abnormally altered components (UCB, unconjugated bilirubin; CA, cholic acid; DCA, deoxycholic acid; LCA, lithocholic acid; CDCA, chenodeoxycholic acid; and UDCA, ursodeoxycholic acid) in ALF mouse serum on the function and expression of P-GP in HCMEC/D3 and MDCK-MDR1 cells, respectively. Cell viability (A,B), rhodamine 123 uptake (C,D), vincristine uptake (E,F), and P-GP expression (G,H) were determined in HCMEC/D3 and MDCK-MDR1 cells after treatment with abnormally altered components for 24 h, respectively. Data are expressed as mean ± SD (n = 4). ∗P < 0.05, ∗∗P < 0.01 vs. control.